Johnson & Johnson: A Safe Haven That's Quietly Becoming A Bit Overpriced (NYSE:JNJ)

Core Insights - The analysis focuses on high-quality companies that can outperform the market over the long term due to competitive advantages and high levels of defensibility [1] Group 1: Company Analysis - Johnson & Johnson (NYSE: JNJ) was rated as a 'Buy' in the last article published in April 2025 [1] - The analysis emphasizes a broad focus on companies across different market capitalizations, from large cap to small cap [1] Group 2: Analyst Background - The analyst has a Master's Degree in Sociology with a focus on organizational and economic sociology, and a Bachelor's Degree in Sociology and History [1]